|
|
||||||||
Istituto di Neurologia, Università Cattolica del S. Cuore, Largo Francesco Vito 1, 00168 Roma, Italy
The scrapie-infected hamster has been considered an excellent model for the study of slow virus diseases of man (Creutzfeldt-Jakob disease) and animals. At the moment no therapy is available for the cure of these fatal central nervous system diseases, although several drugs have been tested. We found that amphotericin B (AmB), a polyene antibiotic, increased the incubation time of scrapie disease in animals infected by either the intraperitoneal or intracerebral route. Hamsters inoculated with a 10% brain suspension of the 263K strain of scrapie showed clinical signs of disease in 54·6 ± 4·7 days. Under AmB treatment (1 mg/kg for 6 days a week) the incubation time increased with the length of treatment, up to a maximum delay of 45 days. AmB may interact with the scrapie agent on cell plasma membranes and may thereby decrease the rate of scrapie replication. However, AmB did not have any effect when administered after the clinical onset of scrapie disease.
Received 19 June 1986;
accepted 10 September 1986.
This article has been cited by other articles:
![]() |
C. R Trevitt and J. Collinge A systematic review of prion therapeutics in experimental models Brain, September 1, 2006; 129(9): 2241 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kocisko, W. S. Caughey, R. E. Race, G. Roper, B. Caughey, and J. D. Morrey A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection Antimicrob. Agents Chemother., February 1, 2006; 50(2): 759 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kocisko and B. Caughey Mefloquine, an Antimalaria Drug with Antiprion Activity In Vitro, Lacks Activity In Vivo J. Virol., January 15, 2006; 80(2): 1044 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carmody, B. Murphy, B. Byrne, P. Power, D. Rai, B. Rawlings, and P. Caffrey Biosynthesis of Amphotericin Derivatives Lacking Exocyclic Carboxyl Groups J. Biol. Chem., October 14, 2005; 280(41): 34420 - 34426. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aguzzi and C. Haass Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease Science, October 31, 2003; 302(5646): 814 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barret, F. Tagliavini, G. Forloni, C. Bate, M. Salmona, L. Colombo, A. De Luigi, L. Limido, S. Suardi, G. Rossi, et al. Evaluation of Quinacrine Treatment for Prion Diseases J. Virol., August 1, 2003; 77(15): 8462 - 8469. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Forloni, S. Iussich, T. Awan, L. Colombo, N. Angeretti, L. Girola, I. Bertani, G. Poli, M. Caramelli, M. Grazia Bruzzone, et al. Tetracyclines affect prion infectivity PNAS, August 6, 2002; 99(16): 10849 - 10854. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sigurdsson, D. R. Brown, M. Daniels, R. J. Kascsak, R. Kascsak, R. Carp, H. C. Meeker, B. Frangione, and T. Wisniewski Immunization Delays the Onset of Prion Disease in Mice Am. J. Pathol., July 1, 2002; 161(1): 13 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Enari, E. Flechsig, and C. Weissmann Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody PNAS, July 19, 2001; (2001) 151242598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mangé, N. Nishida, O. Milhavet, H. E. M. McMahon, D. Casanova, and S. Lehmann Amphotericin B Inhibits the Generation of the Scrapie Isoform of the Prion Protein in Infected Cultures J. Virol., April 1, 2000; 74(7): 3135 - 3140. [Abstract] [Full Text] |
||||
![]() |
S. A. Priola, A. Raines, and W. S. Caughey Porphyrin and Phthalocyanine Antiscrapie Compounds Science, February 25, 2000; 287(5457): 1503 - 1506. [Abstract] [Full Text] |
||||
![]() |
L. lngrosso, F. Pisani, and M. Pocchiari Transmission of the 263K scrapie strain by the dental route J. Gen. Virol., November 1, 1999; 80(11): 3043 - 3047. [Abstract] [Full Text] |
||||
![]() |
R. Demaimay, R. Race, and B. Chesebro Effectiveness of Polyene Antibiotics in Treatment of Transmissible Spongiform Encephalopathy in Transgenic Mice Expressing Syrian Hamster PrP Only in Neurons J. Virol., April 1, 1999; 73(4): 3511 - 3513. [Abstract] [Full Text] |
||||
![]() |
K. Adjou, R Demaimay, J. Deslys, C. Lasmezas, V Beringue, S Demart, F Lamoury, M Seman, and D Dormont MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie J. Gen. Virol., April 1, 1999; 80(4): 1079 - 1085. [Abstract] |
||||
![]() |
S. Caspi, M. Halimi, A. Yanai, S. B. Sasson, A. Taraboulos, and R. Gabizon The Anti-prion Activity of Congo Red. PUTATIVE MECHANISM J. Biol. Chem., February 6, 1998; 273(6): 3484 - 3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tagliavini, R. A. McArthur, B. Canciani, G. Giaccone, M. Porro, M. Bugiani, P. M. Lievens, O. Bugiani, E. Peri, P. Dall'Ara, et al. Effectiveness of Anthracycline Against Experimental Prion Disease in Syrian Hamsters Science, May 16, 1997; 276(5315): 1119 - 1121. [Abstract] [Full Text] |
||||
![]() |
M. Enari, E. Flechsig, and C. Weissmann Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody PNAS, July 31, 2001; 98(16): 9295 - 9299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |